“Effects of Raloxifene Combined with Low-dose Conjugated Estrogen on the Endometrium in Menopausal Women at High Risk for Breast Cancer”, Clinics, vol. 76, p. e2380, Nov. 2021, doi: 10.6061/clinics/2021/e2380.